A celiac test (e.g., HLA-DQ2/DQ8 genotyping or antibody test) is primarily intended for diagnosing or ruling out celiac disease, not for assessing blood sugar. However, celiac disease can indirectly affect blood glucose: untreated celiac causes intestinal damage leading to malabsorption, which may cause blood sugar fluctuations – especially in individuals with concurrent type 1 diabetes (high co-occurrence). A positive genetic test alone does not indicate current blood sugar levels; it only shows genetic predisposition. Antibody tests (tTG-IgA) are relevant for active celiac diagnosis. For blood sugar management in metabolically healthy individuals or type 2 diabetics without celiac suspicion, the test is not useful. Evidence: mechanistic/observational, no direct clinical recommendation for blood sugar screening. Caveat: marketing often overstates the link. If celiac is suspected (e.g., unexplained hypoglycemia, weight loss), consult a physician.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-3d13c127b79a5edca80707b3